Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in
immunocompromised patients. Patients with hematological malignancies undergoing …

Objective: Patients with hematologic malignancies are at substantial risk of developing
invasive fungal infections (IFI) that are associated with substantial morbidity and mortality …

Invasive fungal infections (IFI) remain a leading cause of morbidity and mortality in
immunocompromised patients. This retrospective single-center study analyzed incidence …

Patients with hematologic malignancy and hematopoietic cell transplant (HCT) recipients
are at increased risk for invasive fungal infection (IFI) as a result of immunosuppression or …

Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular
those with haematological malignancies undergoing remission-induction chemotherapy for …

Invasive fungal infection (IFI) causes morbidity and mortality among patients with
hematological malignancies who receive cytotoxic chemotherapy or hematopoietic stem cell …

Patients with haematological malignancies (HM) are at high risk of developing invasive
fungal disease (IFD) with high morbidity and attributable mortality. We reviewed data …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Invasive fungal disease (IFD) is a common cause of morbidity and mortality in patients with
hematologic malignancies, especially among those undergoing allogeneic hematopoietic …

In patients with hematologic malignancies due to immune system disorders, especially
persistent febrile neutropenia, invasive fungal infections (IFI) occur with high mortality …